SFPH proteins as therapeutic targets for a myriad of diseases

Article Properties
Cite
Wang, Dong, et al. “SFPH Proteins As Therapeutic Targets for a Myriad of Diseases”. Bioorganic &Amp; Medicinal Chemistry Letters, vol. 30, no. 22, 2020, p. 127600, https://doi.org/10.1016/j.bmcl.2020.127600.
Wang, D., Tabti, R., Elderwish, S., Djehal, A., Chouha, N., Pinot, F., Yu, P., Nebigil, C. G., & Désaubry, L. (2020). SFPH proteins as therapeutic targets for a myriad of diseases. Bioorganic &Amp; Medicinal Chemistry Letters, 30(22), 127600. https://doi.org/10.1016/j.bmcl.2020.127600
Wang D, Tabti R, Elderwish S, Djehal A, Chouha N, Pinot F, et al. SFPH proteins as therapeutic targets for a myriad of diseases. Bioorganic & Medicinal Chemistry Letters. 2020;30(22):127600.
Refrences
Title Journal Journal Categories Citations Publication Date
A subset of flavaglines inhibits KRAS nanoclustering and activation

Journal of Cell Science
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Genetics
9 2020
Flotillins: At the Intersection of Protein S-Palmitoylation and Lipid-Mediated Signaling

International Journal of Molecular Sciences
  • Science: Biology (General)
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
35 2020
PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis Autophagy
  • Science: Biology (General): Genetics
  • Science: Biology (General): Cytology
194 2020
A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment

Scientific Reports
  • Medicine
  • Science
  • Science: Science (General)
18 2020
Targeting ROCK/LIMK/cofilin signaling pathway in cancer Archives of Pharmacal Research
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
57 2019
Refrences Analysis
Category Category Repetition
Science: Biology (General)17
Science: Biology (General): Cytology11
Science: Biology (General): Genetics10
Science: Chemistry: Organic chemistry: Biochemistry8
Medicine: Medicine (General)7
Medicine: Therapeutics. Pharmacology7
Science: Chemistry6
Science5
Science: Science (General)5
Science: Microbiology5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs4
Medicine4
Science: Chemistry: Analytical chemistry4
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy4
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system3
Medicine: Public aspects of medicine: Toxicology. Poisons3
Medicine: Internal medicine: Infectious and parasitic diseases3
Science: Physics2
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology2
Science: Chemistry: General. Including alchemy2
Science: Zoology1
Science: Botany1
Science: Botany: Plant ecology1
Agriculture: Plant culture1
Agriculture: Animal culture1
Technology: Chemical technology: Polymers and polymer manufacture1
Science: Chemistry: Organic chemistry1
Medicine: Internal medicine: Special situations and conditions1
Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid1
Medicine: Surgery: Anesthesiology1
The category Science: Biology (General) 17 is the most frequently represented among the references in this article. It primarily includes studies from PLOS ONE and European Journal of Medicinal Chemistry. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations Analysis
The category Medicine 2 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled SPFH protein cage — one ring to rule them all and was published in 2021. The most recent citation comes from a 2023 study titled Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy. This article reached its peak citation in 2022, with 4 citations. It has been cited in 11 different journals, 36% of which are open access. Among related journals, the Nature Communications cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year